Imaging biomarkers of NAFLD, NASH, and fibrosis

Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non-alcoholic steatohepatitis (NASH). Liver biopsy is invasive, subject to sampling and interobserver variability, and impractical to scale...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular metabolism (Germany) Jg. 50; S. 101167
Hauptverfasser:	Ajmera, Veeral, Loomba, Rohit
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Germany Elsevier GmbH 01.08.2021 Elsevier
Schlagworte:	Biopsy Disease Progression Elasticity Imaging Techniques - methods Humans Liver - diagnostic imaging Liver - pathology Liver Cirrhosis - diagnosis Liver Cirrhosis - pathology Magnetic Resonance Imaging - methods MR Elastography MRI MRI-PDFF NAFLD NASH Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - pathology Review Severity of Illness Index Significant fibrosis NAFLD NASH Significant fibrosis MRI MR Elastography MRI-PDFF
ISSN:	2212-8778, 2212-8778
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!